266 related articles for article (PubMed ID: 15929954)
1. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
Martinez FJ; Grossman RF; Zadeikis N; Fisher AC; Walker K; Ambruzs ME; Tennenberg AM
Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
Sethi S; Breton J; Wynne B
Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
[TBL] [Abstract][Full Text] [Related]
4. Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients.
Grossman RF; Ambrusz ME; Fisher AC; Khashab MM; Kahn JB
Clin Ther; 2006 Aug; 28(8):1175-1180. PubMed ID: 16982294
[TBL] [Abstract][Full Text] [Related]
5. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
6. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media.
Noel GJ; Blumer JL; Pichichero ME; Hedrick JA; Schwartz RH; Balis DA; Melkote R; Bagchi P; Arguedas A
Pediatr Infect Dis J; 2008 Jun; 27(6):483-9. PubMed ID: 18449063
[TBL] [Abstract][Full Text] [Related]
7. Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity.
Kahn JB; Khashab M; Ambruzs M
Curr Med Res Opin; 2007 Jan; 23(1):1-7. PubMed ID: 17261234
[TBL] [Abstract][Full Text] [Related]
8. Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial.
Graham DR; Talan DA; Nichols RL; Lucasti C; Corrado M; Morgan N; Fowler CL
Clin Infect Dis; 2002 Aug; 35(4):381-9. PubMed ID: 12145720
[TBL] [Abstract][Full Text] [Related]
9. Bacterial etiology of acute otitis media and clinical efficacy of amoxicillin-clavulanate versus azithromycin.
Guven M; Bulut Y; Sezer T; Aladag I; Eyibilen A; Etikan I
Int J Pediatr Otorhinolaryngol; 2006 May; 70(5):915-23. PubMed ID: 16293317
[TBL] [Abstract][Full Text] [Related]
10. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
[TBL] [Abstract][Full Text] [Related]
11. Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study.
Swanson RN; Lainez-Ventosilla A; De Salvo MC; Dunne MW; Amsden GW
Treat Respir Med; 2005; 4(1):31-9. PubMed ID: 15725048
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.
Murray JJ; Emparanza P; Lesinskas E; Tawadrous M; Breen JD
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):194-200. PubMed ID: 16087013
[TBL] [Abstract][Full Text] [Related]
13. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial.
Romano M; Cuomo A; Gravina AG; Miranda A; Iovene MR; Tiso A; Sica M; Rocco A; Salerno R; Marmo R; Federico A; Nardone G
Gut; 2010 Nov; 59(11):1465-70. PubMed ID: 20947881
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
15. [Infectious exacerbation of chronic obstructive pulmonary disease: prospects for high-dose levofloxacin therapy].
Astaf'ev AV; Styrt EA; Sinopal'nikov AI
Klin Med (Mosk); 2013; 91(3):44-50. PubMed ID: 23789452
[TBL] [Abstract][Full Text] [Related]
16. Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval.
Petitpretz P; Choné C; Trémolières F;
Int J Antimicrob Agents; 2007 Jul; 30(1):52-9. PubMed ID: 17512704
[TBL] [Abstract][Full Text] [Related]
17. Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae.
Berry V; Hoover J; Singley C; Woodnutt G
Antimicrob Agents Chemother; 2005 Mar; 49(3):908-15. PubMed ID: 15728883
[TBL] [Abstract][Full Text] [Related]
18. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
19. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
[TBL] [Abstract][Full Text] [Related]
20. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
Conte JE; Golden JA; McIver M; Little E; Zurlinden E
Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]